Expression of SARS-CoV nucleocapsid protein in Bac-to-Bac Baculovirus System and antigenic analysis
10.3969/j.issn.1000-484X.2014.06.001
- VernacularTitle:SASR-CoV核衣壳蛋白在杆状病毒-昆虫系统的克隆表达及抗原性分析
- Author:
Li HUANG
;
Zhiwu YU
;
Yuxian PAN
;
Liwen QIU
;
Wei HAO
;
Xixia DING
;
Xiaoyao CHE
;
Nan YU
- Publication Type:Journal Article
- Keywords:
Severe-acute-respiratory-syndrome-(-SARS-);
SARS-coronavirus-(-SARS-CoV-);
Nucleocapsid-protein;
Baculovirus;
Antigenicity
- From:
Chinese Journal of Immunology
2014;(6):721-725
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To express SARS-CoV nucleocapsid protein in Bac-to-Bac Baculovirus Expression System and analyze the antigenicity of the recombinant protein.Methods: The SARS-CoV nucleocapsid gene was amplified by PCR.The PCR product digested with BamHⅠand SalⅠrestriction endonucleases was cloned into vector pFastBac HTC of Bac-to-Bac Baculovirus expression system.Recombinant plasmid was transformed DH 10Bac cells to obtain the recombinant Bacmid DNA.Recombinant Bacmid DNA was transferred into Sf9 cells which were inducted to express the recombinant protein in High Five cells.After purified by Ni affinity chroma-tography ,the antigenicity of the recombinant protein was analyzed by Western blot and ELISA.Results:Recombinant plasmid was con-structed successfully.The recombinant protein with the relative molecular mass of 48 kD was efficiently expressed in High Five cells and purified successfully by Ni affinity chromatography.Western blot and ELISA analysis showed that the recombinant protein could be spe -cifically recognized by the monoclonal antibody to SARS-CoV N protein and immune serum from rabbits ,respectively.The recombinant protein can specifically reacted with serum from SARS patients ,not with serum from healthy persons and patients infected with hCoV-229 E and hCoV-OC43.Conclusion: SARS-CoV nucleocapsid protein has been expressed successfully in the Bac-to-Bac Baculovirus Expression System ,and obtained good antigenicity.It is preliminary deemed that it can't reacted with serum from patients infected with hCoV-229E and hCoV-OC43.
